MicroPort CardioFlow Medtech Corp. (HK:2160) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MicroPort CardioFlow Medtech Corp. announced that its third-generation transcatheter aortic valve implantation system, VitaFlow Liberty Flex, has received approval from China’s National Medical Products Administration. This advanced system promises enhanced precision and safety in surgeries, potentially boosting operational efficiency and reducing complications. The company aims to lower production costs through its innovative product lifecycle management.
For further insights into HK:2160 stock, check out TipRanks’ Stock Analysis page.